The device is intended for at-home use and aligns with Vagheggi’s professional dermocosmetic positioning.Nuon Medical x Vagheggi
Product Context: Longévité 75.25
The Longévité 75.25 line is informed by research in epigenetics and cellular longevity and is formulated to address 12 visible signs of skin aging. Key treatment objectives include:
- Skin protection and nourishment
- Stimulation and brightening
- Support for facial contour definition
To reinforce these goals, Vagheggi incorporated a dedicated beauty-tech accessory directly into the packaging.
Technology Integration
The device is intended for at-home use and aligns with Vagheggi’s professional dermocosmetic positioning.Nuon Medical x Vagheggi
Integrated technologies include:
- Red light therapy (630 nm)
- Microcurrents
- Controlled warming
- Vibration
The device is intended for at-home use and aligns with Vagheggi’s professional dermocosmetic positioning.
Clinical Evaluation
A usage study was conducted with 20 participants aged 40–65 presenting visible wrinkles.
Protocol:
- Longévité 75.25 day cream applied twice daily for 14 days
- Efficacy Booster Device used once daily for three minutes
Reported outcomes:
- Average wrinkle depth reduction: 14.8%
- Maximum wrinkle depth reduction observed: up to 40%
- 100% of participants reported improvements in:
- Skin firmness
- Radiance
- Hydration
- Lifting and reshaping effect
Participants also described the device as easy to use and comfortable during application.
Industry Takeaway
The collaboration reflects a broader industry shift toward integrated dermocosmetic solutions, combining formulation science with device-enabled application to support treatment performance within professional skin care programs.
